Ongoing legislative developments and the latest experiences with implementing alternative payment mechanisms are just some of the reasons Clifford Goodman, PhD, senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group, is looking forward to the fall meeting of the ACO & Emerging Healthcare Delivery Coalition.
Ongoing legislative developments and the latest experiences with implementing alternative payment mechanisms are just some of the reasons Clifford Goodman, PhD, senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group, is looking forward to the fall meeting of the ACO & Emerging Healthcare Delivery Coalition.
Transcript (slightly modified)
Why should someone attend the fall meeting of the ACO & Emerging Healthcare Delivery Coalition, being held October 26-27 in Nashville, Tennessee?
Thinking about the fall meeting in Nashville, I’m already looking forward to that because of a few things. One is that by then, we’re going to see a lot more of how the healthcare legislation is going to be playing out. What really will have happened to the Affordable Care Act? Will there really be a new AHCA [American Health Care Act] in place? Those contextual trends are going to be very important for understanding where we go next with the ACO Coalition. That’s a very important thing.
Also, I see a trend, or I should say kind of an ongoing continuous development, of shared learning among our people that do attend this meeting on an ongoing basis. We continue to develop, learn from, refine, and then continue to implement these different sort of models, value-based models, for really providing alternative payment mechanisms for accountable care organizations and others to better serve our patient populations.
It’s the changes in the political environment, certainly advances in sciences and the state-of-the-art, and the ongoing exchange of on-the-ground experience that will make an event like that really successful.
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More